Completed NA INTERVENTIONAL 2-arm NCT00828347

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

A Study of Maintenance Therapy After Intravenous Maxacalcitol for Secondary Hyperparathyroidism

Sponsor: Kumamoto University

Conditions Secondary Hyperparathyroidism

Interventions 0.25 μg/day Alfacalcidol 1.0 μg/day Alfacalcidol

Updated 8 times since 2017 Last updated: Dec 16, 2015 Started: Jan 31, 2008 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00828347, this NA trial focuses on Secondary Hyperparathyroidism and remains completed. Sponsored by Kumamoto University, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kumamoto University

Data source: Kumamoto University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kumamoto, Japan